Abstract Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of severe epilepsies accompanied by intellectual disability and other neurodevelopmental features. Using next-generation sequencing, we identified four different de novo mutations in KCNA2, encoding the potassium channel KV1.2, in six isolated patients with epileptic encephalopathy (one mutation recurred three times independently). Four individuals presented with febrile and multiple afebrile, often focal seizure types, multifocal epileptiform discharges strongly activated by sleep, mild to moderate intellectual disability, delayed speech development and sometimes ataxia. Functional studies of the two mutations associated with this phenotype showed almost complete loss of function with a dominant-negative effect. Two further individuals presented with a different and more severe epileptic encephalopathy phenotype. They carried mutations inducing a drastic gain-of-function effect leading to permanently open channels. These results establish KCNA2 as a new gene involved in human neurodevelopmental disorders through two different mechanisms, predicting either hyperexcitability or electrical silencing of KV1.2-expressing neurons.

De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy / Syrbe; Steffen; Hedrich; Ulrike B.S.; Riesch; Erik; Djémié; Tania; Müller; Stephan; Møller; Rikke S.; Maher; Bridget; Hernandez-Hernandez; Laura; Synofzik; Matthis; Caglayan; Hande S.; Arslan; Mutluay; Serratosa; José M.; Nothnagel; Michael; May; Patrick; Krause; Roland; Löffler; Heidrun; Detert; Katja; Dorn; Thomas; Vogt; Heinrich; Krämer; Günter; Schöls; Ludger; Mullis; Primus E.; Linnankivi; Tarja; Lehesjoki; Anna-Elina; Sterbova; Katalin; Craiu; Dana C.; Hoffman-Zacharska; Dorota; Korff; Christian M.; Weber; Yvonne G.; Steinlin; Maja; Gallati; Sabina; Bertsche; Astrid; Bernhard; Matthias K.; Merkenschlager; Andreas; Kiess; Wieland; Gonzalez; Michael; Züchner; Stephan; Palotie; Aarno; Suls; Arvid; De Jonghe; Peter; Helbig; Ingo; Biskup; Saskia; Wolff; Markus; Maljevic; Snezana; Schüle; Rebecca; Sisodiya; Sanjay M.; Weckhuysen; Sarah; Lerche; Holger; Lemke; Johannes R. Collaborators (40) Balling R; Barisic N; Baulac S; Caglayan HS; Craiu DC; De Jonghe P; Depienne C; Gormley P; Guerrini R; Helbig I; Hjalgrim H;Hoffman-Zacharska D; Jähn J; Klein KM; Koeleman BP; Komarek V; Krause R; LeGuern E; Lehesjoki AE; Lemke JR; Lerche H;Marini C; May P; Møller RS; Muhle H; Palotie A; Pal D; Rosenow F; Selmer K; Serratosa JM; Sisodiya SM; Stephani U; Sterbova K; Striano P; Suls A; Talvik T; von Spiczak S; G Weber Y; Weckhuysen S; Zara F Balling R, Barisic N, Baulac S, Caglayan HS, Craiu DC, De Jonghe P, Depienne C, Gormley P, Guerrini R, Helbig I, Hjalgrim H,Hoffman-Zacharska D, Jähn J, Klein KM, Koeleman BP, Komarek V, Krause R, LeGuern E, Lehesjoki AE, Lemke JR, Lerche H,Marini C, May P, Møller RS, Muhle H, Palotie A, Pal D, Rosenow F, Selmer K, Serratosa JM, Sisodiya SM, Stephani U, Sterbova K, Striano P, Suls A, Talvik T, von Spiczak S, G Weber Y, Weckhuysen S, Zara F. - In: NATURE GENETICS. - ISSN 1061-4036. - STAMPA. - 47:(2015), pp. 393-399. [10.1038/ng.3239]

De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy

GUERRINI, RENZO;Marini C;
2015

Abstract

Abstract Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of severe epilepsies accompanied by intellectual disability and other neurodevelopmental features. Using next-generation sequencing, we identified four different de novo mutations in KCNA2, encoding the potassium channel KV1.2, in six isolated patients with epileptic encephalopathy (one mutation recurred three times independently). Four individuals presented with febrile and multiple afebrile, often focal seizure types, multifocal epileptiform discharges strongly activated by sleep, mild to moderate intellectual disability, delayed speech development and sometimes ataxia. Functional studies of the two mutations associated with this phenotype showed almost complete loss of function with a dominant-negative effect. Two further individuals presented with a different and more severe epileptic encephalopathy phenotype. They carried mutations inducing a drastic gain-of-function effect leading to permanently open channels. These results establish KCNA2 as a new gene involved in human neurodevelopmental disorders through two different mechanisms, predicting either hyperexcitability or electrical silencing of KV1.2-expressing neurons.
2015
47
393
399
Syrbe; Steffen; Hedrich; Ulrike B.S.; Riesch; Erik; Djémié; Tania; Müller; Stephan; Møller; Rikke S.; Maher; Bridget; Hernandez-Hernandez; Laura; Synofzik; Matthis; Caglayan; Hande S.; Arslan; Mutluay; Serratosa; José M.; Nothnagel; Michael; May; Patrick; Krause; Roland; Löffler; Heidrun; Detert; Katja; Dorn; Thomas; Vogt; Heinrich; Krämer; Günter; Schöls; Ludger; Mullis; Primus E.; Linnankivi; Tarja; Lehesjoki; Anna-Elina; Sterbova; Katalin; Craiu; Dana C.; Hoffman-Zacharska; Dorota; Korff; Christian M.; Weber; Yvonne G.; Steinlin; Maja; Gallati; Sabina; Bertsche; Astrid; Bernhard; Matthias K.; Merkenschlager; Andreas; Kiess; Wieland; Gonzalez; Michael; Züchner; Stephan; Palotie; Aarno; Suls; Arvid; De Jonghe; Peter; Helbig; Ingo; Biskup; Saskia; Wolff; Markus; Maljevic; Snezana; Schüle; Rebecca; Sisodiya; Sanjay M.; Weckhuysen; Sarah; Lerche; Holger; Lemke; Johannes R. Collaborators (40) Balling R; Barisic N; Baulac S; Caglayan HS; Craiu DC; De Jonghe P; Depienne C; Gormley P; Guerrini R; Helbig I; Hjalgrim H;Hoffman-Zacharska D; Jähn J; Klein KM; Koeleman BP; Komarek V; Krause R; LeGuern E; Lehesjoki AE; Lemke JR; Lerche H;Marini C; May P; Møller RS; Muhle H; Palotie A; Pal D; Rosenow F; Selmer K; Serratosa JM; Sisodiya SM; Stephani U; Sterbova K; Striano P; Suls A; Talvik T; von Spiczak S; G Weber Y; Weckhuysen S; Zara F Balling R, Barisic N, Baulac S, Caglayan HS, Craiu DC, De Jonghe P, Depienne C, Gormley P, Guerrini R, Helbig I, Hjalgrim H,Hoffman-Zacharska D, Jähn J, Klein KM, Koeleman BP, Komarek V, Krause R, LeGuern E, Lehesjoki AE, Lemke JR, Lerche H,Marini C, May P, Møller RS, Muhle H, Palotie A, Pal D, Rosenow F, Selmer K, Serratosa JM, Sisodiya SM, Stephani U, Sterbova K, Striano P, Suls A, Talvik T, von Spiczak S, G Weber Y, Weckhuysen S, Zara F
File in questo prodotto:
File Dimensione Formato  
ng.3239.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 893.83 kB
Formato Adobe PDF
893.83 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1013068
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 201
  • ???jsp.display-item.citation.isi??? 191
social impact